Developer docs
API playgroundTry for free, no card

Search company profiles

SNT Biotech

Full company profile

uuid000c44e

Namestring
SNT Biotech
Legal namestring
SNT Biotech
Websiteurl
sntbiotech.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

SNT Biotech is a privately held healthcare screening company founded in 2011 and headquartered in the Chicago area, operating two interrelated lines of business: a Shopify-based e-commerce storefront selling medical and laboratory supplies and PPE to healthcare buyers, and a B2B at-home screening platform sold to health plans, employers, FQHCs, and provider groups. The screening platform combines multilingual omni-channel outreach (SMS, voice, email, print), custom kitting and fulfillment, and an owned CLIA- and COLA-certified laboratory that processes samples in-house with full chain-of-custody, eliminating third-party hand-offs. The flagship clinical product is the FDA-cleared (April 2026) BD Onclarity HPV Self-Collection Kit for at-home cervical cancer screening, distributed nationwide through a partnership with Waters Corporation announced in June 2026; the broader screening menu also covers colorectal cancer (FIT), diabetes (HbA1c), kidney health (KED), biometrics, and chlamydia/gonorrhea testing, with HEDIS-ready population health dashboards for quality teams.

Revenue is generated through subscription/recurring contracts for screening program services (kit distribution, outreach, lab processing, reporting) alongside one-time product sales through the e-commerce storefront at price points ranging from approximately $15 to $1,700+. Pricing is not publicly disclosed for healthcare contracts, which are negotiated B2B; consumer product pricing is listed online. The company is led by founder and CEO Shital Daftari, holds WBENC, NMSDC, WOSB, BEP, and Minority Business Enterprise certifications supporting supplier diversity contracting, and has been recognized on Inc. 5000, FAST50, and ABA22 Silver, with media visibility via NBC 5 Chicago's Tech Trends segment.

Short descriptiontext

SNT Biotech is a Chicago-area healthcare company that runs an at-home population health screening platform for health plans, employers, FQHCs, and providers, paired with a medical supplies and PPE e-commerce storefront, processing samples in its own CLIA/COLA-certified laboratory.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPlainfield, United States
HQ citystring
Plainfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home diagnostic screening, clinical laboratory services, medical laboratory supplies, population health screening, cervical cancer screening
Industry4 codes
PRIMARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
At-Home Diagnostic Screening Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1At-Home Screening Program Services
TypeSubscription Recurring
Description

Comprehensive at-home screening programs sold to health plans and employers, including kit delivery, lab processing, outreach engagement, and reporting. Revenue generated through contracts with healthcare organizations for population health screening services.

sntbiotech.com
2Medical and Laboratory Supplies
TypeHardware Sales
Description

Wide range of medical supplies and laboratory products sold through e-commerce storefront, including blood collection products, needles, syringes, diagnostic equipment, and PPE. One-time product sales to healthcare facilities and providers.

sntbiotech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SNT Biotech operates an end-to-end at-home screening platform that delivers FDA-cleared self-collection kits (HPV, FIT, HbA1c, KED, CT/NG) directly to members' homes, processes samples in its own CLIA- and COLA-certified laboratory, and provides HEDIS-ready population health reporting to health plans, employers, and providers. The company supplements these screening programs with a broad e-commerce storefront selling medical and laboratory supplies (blood collection products, needles, syringes, lab equipment, PPE) to healthcare facilities and individual practitioners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 60% of cervical cancer diagnoses occur in unscreened or under-screened individuals - SNT Biotech addresses this critical screening gap
+3 more records
Product overview1 text field

SNT Biotech operates as a platform-plus-services company providing comprehensive at-home screening solutions for health plans and healthcare organizations. The core offering is an integrated at-home screening platform that manages the full workflow from member identification and multilingual engagement through kit delivery, lab processing, and results reporting. The platform's flagship product is the FDA-cleared Onclarity™ HPV Self-Collection Kit for cervical cancer screening, supported by additional screening tests including FIT Colon Cancer Screening, HbA1C Diabetes Monitoring, Biometrics Screening, KED (Kidney Health Evaluation), and CT/NG testing. Key platform capabilities include Omni-Channel Multilingual Outreach, Real-Time Population Health Dashboards, and CLIA & COLA Certified Laboratory Services. The company also offers customized kitting and fulfillment, co-branded educational portals, and data analytics for health equity and HEDIS score improvement. SNT Biotech positions itself as a minority and women-owned business enterprise supporting supplier diversity initiatives.

Product and service7 records
1At-Home Cervical Cancer Screening (Onclarity HPV Self-Collection Kit)
CategoryCervical Cancer Screening
Description

FDA-cleared at-home HPV self-collection kit for cervical cancer screening. Delivers self-collection kits to members' homes, processes samples using the BD Onclarity HPV assay with extended genotyping at the company's CLIA-accredited laboratory, and provides HEDIS-ready data reporting for health plans.

2FIT Colon Cancer Screening
CategoryColorectal Cancer Screening
Description

At-home fecal immunochemical test (FIT) that detects hidden blood in stool as an early indicator of colon cancer, providing a simple at-home solution for early detection and prevention for health plan members and employers.

3HbA1c Diabetes Test
CategoryDiabetes Screening
Description

At-home test that measures average blood sugar levels over the past three months, offering vital insights into diabetes management and control for health plan members and employer wellness programs.

4Biometrics Screening
CategoryWellness Screening
Description

At-home screening providing a complete overview of key health metrics including blood pressure, cholesterol, and glucose levels to help identify potential health risks as part of population health programs.

5KED (Kidney Health Evaluation for Patients with Diabetes)
CategoryKidney Health Screening
Description

Kidney health screening designed for diabetes patients that monitors kidney function to detect early signs of kidney disease and prevent complications, supporting HEDIS quality measures.

6CT/NG (Chlamydia and Gonorrhea) Test
CategorySexual Health Screening
Description

At-home screening test for chlamydia and gonorrhea detection as part of comprehensive sexual health screening programs for health plan members.

7Medical and Laboratory Supplies (E-commerce)
CategoryMedical and Laboratory Supplies
Description

E-commerce storefront selling a wide range of medical supplies and laboratory products including blood collection products, needles, syringes, diagnostic equipment, lab supplies, PPE, and wound care items to healthcare facilities and providers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-25
Description

SNT Biotech announced a go-to-market partnership with Waters Corporation to distribute the FDA-cleared Onclarity HPV Self-Collection Kit, described as the most comprehensive at-home cervical cancer screening tool available in the U.S. The partnership combines SNT Biotech's patient engagement and lab analysis platform with Waters' distribution network to expand access to cervical cancer screening for underserved women nationwide. The kit, enabled by the BD Onclarity HPV Assay, detects 14 high-risk HPV genotypes.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

At-home diagnostic testing company serving consumers, employers, and health plans with self-collection kits processed in owned labs, a near-identical operating model to SNT Biotech's at-home screening platform across multiple conditions.

TypeDirect peer
Description

Population health technology company delivering at-home screening and lab testing programs to health plans and employers, with overlapping women's health, cancer screening, and HEDIS closure offerings that directly compete with SNT Biotech.

TypeDirect peer
Description

Direct at-home diagnostics competitor offering consumer and health plan screening tests (including HPV and women's health panels) with integrated lab processing and engagement workflows, directly overlapping SNT Biotech's at-home screening platform model.

4Ro (Roman)
TypeDirect peer
Description

Digital health company offering at-home diagnostics and telehealth services, including women's health and screening panels, with direct-to-consumer and B2B distribution that competes for the same health plan screening dollars as SNT Biotech.

TypeEmerging player
Description

Consumer-focused at-home genetic and health testing company with a CLIA-validated lab and direct-to-consumer plus emerging health plan channels, providing partial overlap with SNT Biotech's model of consumer-friendly at-home diagnostics backed by an owned lab.

6Cue Health
TypeEmerging player
Description

At-home diagnostic testing company with FDA-cleared molecular tests marketed to consumers and enterprise customers, providing partial overlap with SNT Biotech's FDA-cleared self-collection approach in the broader at-home diagnostics category.

TypeBroad incumbent
Description

National clinical laboratory network providing diagnostic testing, including HPV and population health screening, to health plans and providers. As a broad incumbent, Labcorp competes for the same enterprise screening contracts that SNT Biotech pursues with health plans.

TypeDirect peer
Description

Population health testing platform that connects health plans and employers with at-home screening programs (including colorectal, diabetes, and women's health), with very similar HEDIS-oriented use cases and target customer base to SNT Biotech.

TypeBroad incumbent
Description

One of the largest U.S. clinical laboratory networks offering broad diagnostic testing services to health plans, providers, and employers. As a broad incumbent, Quest competes for population health screening contracts that SNT Biotech targets, though from a far larger and more diversified platform.

TypeBroad incumbent
Description

Digital health platform offering at-home lab testing and screening services alongside telehealth, with a broad consumer and employer-facing footprint that intersects SNT Biotech's at-home diagnostic and women's health screening categories at a much larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SNT Biotech

At-Home Diagnostic Screening Servicessntbiotech.com

SNT Biotech is a Chicago-area healthcare company that runs an at-home population health screening platform for health plans, employers, FQHCs, and providers, paired with a medical supplies and PPE e-commerce storefront, processing samples in its own CLIA/COLA-certified laboratory.

What SNT Biotech does

SNT Biotech is a privately held healthcare screening company founded in 2011 and headquartered in the Chicago area, operating two interrelated lines of business: a Shopify-based e-commerce storefront selling medical and laboratory supplies and PPE to healthcare buyers, and a B2B at-home screening platform sold to health plans, employers, FQHCs, and provider groups. The screening platform combines multilingual omni-channel outreach (SMS, voice, email, print), custom kitting and fulfillment, and an owned CLIA- and COLA-certified laboratory that processes samples in-house with full chain-of-custody, eliminating third-party hand-offs. The flagship clinical product is the FDA-cleared (April 2026) BD Onclarity HPV Self-Collection Kit for at-home cervical cancer screening, distributed nationwide through a partnership with Waters Corporation announced in June 2026; the broader screening menu also covers colorectal cancer (FIT), diabetes (HbA1c), kidney health (KED), biometrics, and chlamydia/gonorrhea testing, with HEDIS-ready population health dashboards for quality teams.

Revenue is generated through subscription/recurring contracts for screening program services (kit distribution, outreach, lab processing, reporting) alongside one-time product sales through the e-commerce storefront at price points ranging from approximately $15 to $1,700+. Pricing is not publicly disclosed for healthcare contracts, which are negotiated B2B; consumer product pricing is listed online. The company is led by founder and CEO Shital Daftari, holds WBENC, NMSDC, WOSB, BEP, and Minority Business Enterprise certifications supporting supplier diversity contracting, and has been recognized on Inc. 5000, FAST50, and ABA22 Silver, with media visibility via NBC 5 Chicago's Tech Trends segment.

SNT Biotech firmographics

Firmographics
Name
SNT Biotech
Legal name
SNT Biotech
Website
https://sntbiotech.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
SNT Biotech is a Chicago-area healthcare company that runs an at-home population health screening platform for health plans, employers, FQHCs, and providers, paired with a medical supplies and PPE e-commerce storefront, processing samples in its own CLIA/COLA-certified laboratory.
Ownership category
akta.pro rank

SNT Biotech industry classification

Industry
Product category
At-Home Diagnostic Screening Services
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • At-home diagnostic screening
  • Clinical laboratory services
  • Medical laboratory supplies
  • Population health screening
  • Cervical cancer screening

Where SNT Biotech is headquartered

Location

Headquarters

HQ city
Plainfield
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SNT Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales

Revenue model

  1. At-Home Screening Program Services: Comprehensive at-home screening programs sold to health plans and employers, including kit delivery, lab processing, outreach engagement, and reporting. Revenue generated through contracts with healthcare organizations for population health screening services.
  2. Medical and Laboratory Supplies: Wide range of medical supplies and laboratory products sold through e-commerce storefront, including blood collection products, needles, syringes, diagnostic equipment, and PPE. One-time product sales to healthcare facilities and providers.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

SNT Biotech product offering

Product offering

Core offering

SNT Biotech operates an end-to-end at-home screening platform that delivers FDA-cleared self-collection kits (HPV, FIT, HbA1c, KED, CT/NG) directly to members' homes, processes samples in its own CLIA- and COLA-certified laboratory, and provides HEDIS-ready population health reporting to health plans, employers, and providers. The company supplements these screening programs with a broad e-commerce storefront selling medical and laboratory supplies (blood collection products, needles, syringes, lab equipment, PPE) to healthcare facilities and individual practitioners.

Product overview

SNT Biotech operates as a platform-plus-services company providing comprehensive at-home screening solutions for health plans and healthcare organizations. The core offering is an integrated at-home screening platform that manages the full workflow from member identification and multilingual engagement through kit delivery, lab processing, and results reporting. The platform's flagship product is the FDA-cleared Onclarity™ HPV Self-Collection Kit for cervical cancer screening, supported by additional screening tests including FIT Colon Cancer Screening, HbA1C Diabetes Monitoring, Biometrics Screening, KED (Kidney Health Evaluation), and CT/NG testing. Key platform capabilities include Omni-Channel Multilingual Outreach, Real-Time Population Health Dashboards, and CLIA & COLA Certified Laboratory Services. The company also offers customized kitting and fulfillment, co-branded educational portals, and data analytics for health equity and HEDIS score improvement. SNT Biotech positions itself as a minority and women-owned business enterprise supporting supplier diversity initiatives.

Differentiator

Problem solved

Functional benefit

Products and services

  • At-Home Cervical Cancer Screening (Onclarity HPV Self-Collection Kit) FDA-cleared at-home HPV self-collection kit for cervical cancer screening. Delivers self-collection kits to members' homes, processes samples using the BD Onclarity HPV assay with extended genotyping at the company's CLIA-accredited laboratory, and provides HEDIS-ready data reporting for health plans.
  • FIT Colon Cancer Screening At-home fecal immunochemical test (FIT) that detects hidden blood in stool as an early indicator of colon cancer, providing a simple at-home solution for early detection and prevention for health plan members and employers.
  • HbA1c Diabetes Test At-home test that measures average blood sugar levels over the past three months, offering vital insights into diabetes management and control for health plan members and employer wellness programs.
  • Biometrics Screening At-home screening providing a complete overview of key health metrics including blood pressure, cholesterol, and glucose levels to help identify potential health risks as part of population health programs.
  • KED (Kidney Health Evaluation for Patients with Diabetes) Kidney health screening designed for diabetes patients that monitors kidney function to detect early signs of kidney disease and prevent complications, supporting HEDIS quality measures.
  • CT/NG (Chlamydia and Gonorrhea) Test At-home screening test for chlamydia and gonorrhea detection as part of comprehensive sexual health screening programs for health plan members.
  • Medical and Laboratory Supplies (E-commerce) E-commerce storefront selling a wide range of medical supplies and laboratory products including blood collection products, needles, syringes, diagnostic equipment, lab supplies, PPE, and wound care items to healthcare facilities and providers.

Quantifiable outcome

  • 60% of cervical cancer diagnoses occur in unscreened or under-screened individuals - SNT Biotech addresses this critical screening gap
  • +3 more outcomes

Companies that use SNT Biotech

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles4 records

SNT Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SNT Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Waters CorporationflagshipChannel Partner/ Reseller/ Distributor · 25 June 2026SNT Biotech announced a go-to-market partnership with Waters Corporation to distribute the FDA-cleared Onclarity HPV Self-Collection Kit, described as the most comprehensive at-home cervical cancer screening tool available in the U.S. The partnership combines SNT Biotech's patient engagement and lab analysis platform with Waters' distribution network to expand access to cervical cancer screening for underserved women nationwide. The kit, enabled by the BD Onclarity HPV Assay, detects 14 high-risk HPV genotypes.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

SNT Biotech competitors and assessment

Company assessment

Direct peers

  • LetsGetChecked: At-home diagnostic testing company serving consumers, employers, and health plans with self-collection kits processed in owned labs, a near-identical operating model to SNT Biotech's at-home screening platform across multiple conditions.
  • Color Health: Population health technology company delivering at-home screening and lab testing programs to health plans and employers, with overlapping women's health, cancer screening, and HEDIS closure offerings that directly compete with SNT Biotech.
  • Everlywell: Direct at-home diagnostics competitor offering consumer and health plan screening tests (including HPV and women's health panels) with integrated lab processing and engagement workflows, directly overlapping SNT Biotech's at-home screening platform model.
  • Ro (Roman): Digital health company offering at-home diagnostics and telehealth services, including women's health and screening panels, with direct-to-consumer and B2B distribution that competes for the same health plan screening dollars as SNT Biotech.
  • BioIQ: Population health testing platform that connects health plans and employers with at-home screening programs (including colorectal, diabetes, and women's health), with very similar HEDIS-oriented use cases and target customer base to SNT Biotech.

Emerging players

  • 23andMe: Consumer-focused at-home genetic and health testing company with a CLIA-validated lab and direct-to-consumer plus emerging health plan channels, providing partial overlap with SNT Biotech's model of consumer-friendly at-home diagnostics backed by an owned lab.
  • Cue Health: At-home diagnostic testing company with FDA-cleared molecular tests marketed to consumers and enterprise customers, providing partial overlap with SNT Biotech's FDA-cleared self-collection approach in the broader at-home diagnostics category.

Broad incumbents

  • Labcorp: National clinical laboratory network providing diagnostic testing, including HPV and population health screening, to health plans and providers. As a broad incumbent, Labcorp competes for the same enterprise screening contracts that SNT Biotech pursues with health plans.
  • Quest Diagnostics: One of the largest U.S. clinical laboratory networks offering broad diagnostic testing services to health plans, providers, and employers. As a broad incumbent, Quest competes for population health screening contracts that SNT Biotech targets, though from a far larger and more diversified platform.
  • Hims & Hers Health: Digital health platform offering at-home lab testing and screening services alongside telehealth, with a broad consumer and employer-facing footprint that intersects SNT Biotech's at-home diagnostic and women's health screening categories at a much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

SNT Biotech social profiles

Digital presence

SNT Biotech compliance and trust

Trust signal

Compliance8 records

SNT Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SNT Biotech leadership team

Management profile

Number of profiles

Profiles1 record

SNT Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SNT Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SNT Biotech

What does SNT Biotech do?

SNT Biotech operates an end-to-end at-home screening platform that delivers FDA-cleared self-collection kits (HPV, FIT, HbA1c, KED, CT/NG) directly to members' homes, processes samples in its own CLIA- and COLA-certified laboratory, and provides HEDIS-ready population health reporting to health plans, employers, and providers. The company supplements these screening programs with a broad e-commerce storefront selling medical and laboratory supplies (blood collection products, needles, syringes, lab equipment, PPE) to healthcare facilities and individual practitioners.

Is SNT Biotech a public or private company?

SNT Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SNT Biotech founded?

SNT Biotech was founded in 2011. It employs 1 to 10 people.

Where is SNT Biotech based?

SNT Biotech is headquartered in Plainfield, United States, in the North America region.

How does SNT Biotech make money?

Two revenue lines are on record. At-Home Screening Program Services are the primary driver. The others are medical and Laboratory Supplies.

Who are SNT Biotech's main competitors?

Direct peers on record are LetsGetChecked, Color Health, Everlywell, Ro (Roman) and BioIQ. Emerging players are 23andMe and Cue Health. Broad incumbents are Labcorp, Quest Diagnostics and Hims & Hers Health.

Does SNT Biotech have an API?

No public API is recorded for SNT Biotech.

What industry is SNT Biotech in?

SNT Biotech's product category is At-Home Diagnostic Screening Services. Its primary akta.pro industry code is CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournSNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to PatientsSNT Biotech announced a partnership with Waters Corporation to distribute The Onclarity™ HPV Self-Collection Kit, an FDA-cleared at-home cervical cancer screening tool, to expand access nationwide. The kit, enabled by the BD Onclarity™ HPV Assay, detects 14 high-risk HPV genotypes and addresses a critical gap as approximately 60% of cervical cancer diagnoses occur in unscreened or under-screened individuals. SNT Biotech's platform combines patient identification, multilingual engagement, and lab processing to improve screening completion and return rates for underserved populations, with the goal of reducing cervical cancer deaths.PR NewswireSNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to PatientsSNT Biotech announced a go-to-market partnership with Waters Corporation to distribute the FDA-cleared Onclarity™ HPV Self-Collection Kit, described as the most comprehensive at-home cervical cancer screening tool available in the U.S. The partnership aims to expand access to cervical cancer screening for underserved women by combining SNT Biotech's patient engagement and lab analysis platform with Waters' distribution network. The platform addresses barriers to screening by delivering kits directly to overdue members and providing multilingual engagement, with the goal of significantly improving completion and return rates that historically remain in the single digits.BioSpaceSNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to PatientsSNT Biotech announced a partnership with Waters Corporation to distribute The Onclarity HPV Self-Collection Kit, an FDA-cleared at-home cervical cancer screening tool. The kit detects 14 high-risk HPV genotypes, and federal guidelines cover self-collected screening at no cost to members by 2027. The company aims to boost screening and return rates for underserved populations.PR NewswireSNT Biotech Recognized as One of Chicago's Fastest Growing CompaniesSNT Biotech, an Illinois-based distributor of medical and laboratory supplies, was named No. 21 on Crain's Chicago Business Fast 50 2023 list and included in the Women Presidents Organization's 50 Fastest Growing Women-Led/Owned Companies for the third consecutive year. Launched in 2020 by Shital Daftari, the company has grown to offer over 100,000 products from more than 500 medical supply brands and serves hospitals and laboratories across the United States. The recognitions add to a series of awards the company and its CEO received in 2022, including the Silver Stevie Award for Fastest Growing Company of the Year and a ranking at No. 264 on the Inc. 5000 list.PR NewswireChicago Business Owner Named Ernst & Young Entrepreneur Of The Year® 2022 Midwest Award FinalistShital Daftari, owner of Saris and Things, has been named a finalist for the Ernst & Young Entrepreneur Of The Year® 2022 Midwest Award for her pandemic-driven business pivot. During the pandemic, she shifted her Indian clothing e-commerce business to medical supply distribution under SNT Biotech, achieving over 2,000% growth from 2019 to 2021. Daftari has also received multiple other recognitions this year, including being named a Top 50 Fastest Growing Woman Owned/Led Business and winning the Silver Stevie Award for Fastest Growing Company of the Year.